Insider Trading disclosures for Vascular Biogenics Ltd
The latest disclosure was made by Sam Backenroth in Vascular Biogenics Ltd where a trade of 525,000
Ordinary Shares done
was reported to US exchanges on March 31, 2023.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Sam Backenroth
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
525,000 |
525,000
(1%)
|
1%
|
|
-
|
Ordinary Shares |
|
Sam Backenroth
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2023 |
525,000 |
175,000
|
-
|
|
-
|
Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges